The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Expanding antibiotic, vaccine, and diagnostics development and access to tackle antimicrobial resistance
Open accessAbstract
The increasing number of bacterial infections globally that do not respond to any available antibiotics indicates a need to invest in-and ensure access to-new antibiotics, vaccines, and diagnostics. The traditional model of drug development, which depends on substantial revenues to motivate investment, is no longer economically viable without push and pull incentives. Moreover, drugs developed through these mechanisms are unlikely to be affordable for all patients in need, particularly in low-income and middle-income countries. New, publicly funded models based on public-private partnerships could support investment in antibiotics and novel alternatives, and lower patients' out-of-pocket costs, making drugs more accessible. Cost reductions can be achieved with public goods, such as clinical trial networks and platform-based quality assurance, manufacturing, and product development support. Preserving antibiotic effectiveness relies on accurate and timely diagnosis; however scaling up diagnostics faces technological, economic, and behavioural challenges. New technologies appeared during the COVID-19 pandemic, but there is a need for a deeper understanding of market, physician, and consumer behaviour to improve the use of diagnostics in patient management. Ensuring sustainable access to antibiotics also requires infection prevention. Vaccines offer the potential to prevent infections from drug-resistant pathogens, but funding for vaccine development has been scarce in this context. The High-Level Meeting of the UN General Assembly in 2024 offers an opportunity to rethink how research and development can be reoriented to serve disease management, prevention, patient access, and antibiotic stewardship.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
Murray, C. J. L., Ikuta, K. S., Sharara, F., Swetschinski, L., Robles Aguilar, G., Gray, A., Han, C., Bisignano, C., Rao, P., Wool, E., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(21)02724-0 · Cited by 16,316
Innovation in the pharmaceutical industry: New estimates of R&D costs
DiMasi, J. A., Grabowski, H. G., & Hansen, R. W. (2016) · Journal of Health Economics · doi:10.1016/j.jhealeco.2016.01.012 · Cited by 3,359
Ikuta, K. S., Swetschinski, L. R., Robles Aguilar, G., Sharara, F., Mestrovic, T., Gray, A. P., Davis Weaver, N., Wool, E. E., Han, C., Gershberg Hayoon, A., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)02185-7 · Cited by 2,235
Access to effective antimicrobials: a worldwide challenge
Laxminarayan, R., Matsoso, P., Pant, S., Brower, C., Røttingen, J.-A., Klugman, K., & Davies, S. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00474-2 · Cited by 1,465
Self-citationPhage therapy: From biological mechanisms to future directions
Strathdee, S. A., Hatfull, G. F., Mutalik, V. K., & Schooley, R. T. (2023) · Cell · doi:10.1016/j.cell.2022.11.017 · Cited by 817
Self-citationEpidemiology and Diagnostics of Carbapenem Resistance in Gram-negative Bacteria
Nordmann, P., & Poirel, L. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz824 · Cited by 729
The scope of the antimicrobial resistance challenge
Okeke, I. N., de Kraker, M. E. A., Boeckel, T. P. V., Kumar, C. K., Schmitt, H., Gales, A. C., Bertagnolio, S., Sharland, M., & Laxminarayan, R. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00876-6 · Cited by 516
Self-citationThe Lancet Commission on diagnostics: transforming access to diagnostics
Fleming, K. A., Horton, S., Wilson, M. L., Atun, R. A., DeStigter, K. K., Flanigan, J. S., Sayed, S., Adam, P., Aguilar, B., Andronikou, S., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00673-5 · Cited by 506
Cals, J., Butler, C., Hopstaken, R., Hood, K., & Dinant, G. (2009) · BMJ · doi:10.1136/bmj.b1374 · Cited by 499
Effects of Vaccination on Invasive Pneumococcal Disease in South Africa
von Gottberg, A., de Gouveia, L., Tempia, S., Quan, V., Meiring, S. T., von Mollendorf, C., Madhi, S. A., Zell, E. R., Verani, J. R., O’Brien, K. L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1401914 · Cited by 367
Cited by
Sorted by citations
Naghavi, M., Vollset, S. E., Ikuta, K. S., Swetschinski, L. R., Gray, A. P., Wool, E. E., Robles Aguilar, G., Mestrovic, T., Smith, G., Han, C., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01867-1 · Cited by 3,791
Self-citationSati, H. F., Carrara, E., Savoldi, A., Hansen, P., Garlasco, J., Campagnaro, E., Boccia, S., Castillo-Polo, J. A., Magrini, E., García-Vello, P., et al. (2025) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(25)00118-5 · Cited by 1,129
Antimicrobial resistance: a concise update
Ho, C. S., Wong, C. T. H., Aung, T. T., Lakshminarayanan, R., Mehta, J. S., Rauz, S., McNally, A., Kintses, B., Peacock, S. J., de la Fuente‐Núñez, C., et al. (2024) · The Lancet Microbe · doi:10.1016/j.lanmic.2024.07.010 · Cited by 661
The scope of the antimicrobial resistance challenge
Okeke, I. N., de Kraker, M. E. A., Boeckel, T. P. V., Kumar, C. K., Schmitt, H., Gales, A. C., Bertagnolio, S., Sharland, M., & Laxminarayan, R. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00876-6 · Cited by 516
Self-citationLewnard, J. A., Charani, E., Gleason, A., Hsu, L. Y., Khan, W. A., Karkey, A., Chandler, C. I. R., Mashe, T., Khan, E. A., Bulabula, A. N. H., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00862-6 · Cited by 220
Self-citationGlobal health 2050: the path to halving premature death by mid-century
Jamison, D. T., Summers, L. H., Chang, A. Y., Karlsson, O., Mao, W., Norheim, O. F., Ogbuoji, O., Schäferhoff, M., Watkins, D., Adeyi, O., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01439-9 · Cited by 125
Mendelson, M., Lewnard, J. A., Sharland, M., Cook, A., Pouwels, K. B., Alimi, Y. H., Mpundu, M. M., Wesangula, E., Weese, J. S., Røttingen, J., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01019-5 · Cited by 113
Self-citationCurrent economic and regulatory challenges in developing antibiotics for Gram-negative bacteria
Gargate, N., Laws, M., & Rahman, K. M. (2025) · npj Antimicrobials and Resistance · doi:10.1038/s44259-025-00123-1 · Cited by 105
Natanzi, A. S., Poudineh, M., Karimi, E., Khaledi, A., & Kashani, H. H. (2025) · BMC Medicine · doi:10.1186/s12916-025-04323-4 · Cited by 77
Naylor, N. R., Hasso-Agopsowicz, M., Kim, C., Ma, Y., Frost, I., Abbas, K., Aguilar, G., Fuller, N. M., Robotham, J. V., & Jit, M. (2025) · BMJ Global Health · doi:10.1136/bmjgh-2024-016249 · Cited by 52
Jia, F., Guan, J., Wang, J., Li, M., Zhang, Y., Xie, L., Han, P., He, L., Huang, X. R., Lan, J., et al. (2024) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2024.114335 · Cited by 51
Global health perspectives on antibacterial drug discovery and the preclinical pipeline
Theuretzbacher, U., Jumde, R. P., Hennessy, A. J., Cohn, J., & Piddock, L. J. V. (2025) · Nature Reviews Microbiology · doi:10.1038/s41579-025-01167-w · Cited by 55
Self-citationALjohni, M. S., Harun‐Ur‐Rashid, M., & Selim, S. (2025) · Microbial Pathogenesis · doi:10.1016/j.micpath.2024.107275 · Cited by 44
One Health approaches to tackling antimicrobial resistance
Woolhouse, M. E. J. (2024) · Science in One Health · doi:10.1016/j.soh.2024.100082 · Cited by 47
Mishra, A., Dwivedi, R., Faure, K., Morgan, D. J., & Cohn, J. (2025) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(25)00108-2 · Cited by 31
Self-citationSustainable antimicrobial resistance surveillance: time for a global funding mechanism
Painter, C., Limmathurotsakul, D., Roberts, T., van Doorn, H. R., Mayxay, M., Lubell, Y., Day, N. P. J., Turner, P., & Ashley, E. A. (2024) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(24)00649-2 · Cited by 24
Modified alginates for precision drug delivery: Advances in controlled-release and targeting systems
Shahrbabak, S. M., Jalali, S. M., Fathabadi, M. F., Tayebi-Khorrami, V., Amirinejad, M., Forootan, S., Saberifar, M., Fadaei, M. R., Najafi, Z., & Askari, V. R. (2025) · International Journal of Pharmaceutics X · doi:10.1016/j.ijpx.2025.100381 · Cited by 26
Xu, T., Wang, T., Hu, L., Han, N., Zhong, Y., Dai, C., Liu, J., Guo, Y., & Yang, R. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c03478 · Cited by 24
Engineered Nanoparticles for Combating Drug-Resistant Bacteria and Bacterial Biofilms
Печникова, Н. А., Poimenidou, M., Patsidou, C., Zafeiriou-Chatziefraimidou, M., Iliadis, I., & Yaremenko, A. V. (2025) · ACS Nano Medicine · doi:10.1021/acsnanomed.5c00060 · Cited by 26
A Review on the Prevalence and Treatment of Antibiotic Resistance Genes in Hospital Wastewater
Lan, L., Wang, Y., Chen, Y., Wang, T. T., Zhang, J., & Tan, B. (2025) · Toxics · doi:10.3390/toxics13040263 · Cited by 19
Khaskheli, M. A., Nizamani, M. M., Tarafder, E., Das, D., Nosheen, S., Muhae‐Ud‐Din, G., Khaskheli, R. A., Ren, M.-J., Wang, Y., & Yang, S. (2025) · Journal of Fungi · doi:10.3390/jof11030207 · Cited by 18
Lu, Y., Guo, Y., Guo, X., Zhang, S., Liu, F., Ding, S., Wang, D., Wang, Y., Li, K., Wang, Y., et al. (2026) · Dental Research · doi:10.1016/j.dtrs.2025.100008 · Cited by 17
Climate change and antimicrobial resistance
Kalanxhi, E., & Laxminarayan, R. (2026) · Nature Reviews Microbiology · doi:10.1038/s41579-026-01285-z · Cited by 24
Self-citationSakagianni, A., Koufopoulou, C., Koufopoulos, P., Feretzakis, G., Kalles, D., Paxinou, E., Myrianthefs, P. M., & Verykios, V. S. (2024) · Antibiotics · doi:10.3390/antibiotics13100996 · Cited by 19
Ahmed, A. A., Mekky, A. E. M., & Sanad, S. M. H. (2024) · Synthetic Communications · doi:10.1080/00397911.2024.2428653 · Cited by 15
Magnetic field-driven nanospears for enhancing antibacterial strategy
Xu, Y., Wang, K., Luo, T., Fang, Q., Zhang, J., Leung, K. C., Gong, X., & Xuan, S. (2025) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2025.02.177 · Cited by 14
Antimicrobials in serious illness and end-of-life care: lifting the veil of silence
Rosa, W. E., Pandey, S., Wisniewski, R., Blinderman, C. D., Cheong, W. L., Correa‐Morales, J. E., Cubides-Díaz, D. A., Folorunso, S. A., Gafer, N., Marhoom, M., et al. (2025) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(24)00832-6 · Cited by 16
Renz, J., Dauda, K. A., Aga, O. N. L., Díaz‐Uriarte, R., Löhr, I. H., Blomberg, B., & Johnston, I. G. (2025) · mBio · doi:10.1128/mbio.00488-25 · Cited by 25
El‐Sayed, E. R., El-Sayyad, G. S., Abdel‐Fatah, S. S., El-Batal, A. I., & Boratyński, F. (2024) · Microbial Cell Factories · doi:10.1186/s12934-024-02533-8 · Cited by 14
Enrico Baraldi, A., Årdal, C., Aho, E., Popescu, G.-A., & Melaku, T. (2024) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2024.11.012 · Cited by 14
Wang, Z., Zhu, C., Zhao, F., Shi, X., Liu, J., & Shi, J. (2025) · Advanced Functional Materials · doi:10.1002/adfm.202416594 · Cited by 14
Chen, L., Du, Y., Zhao, Y., Peng, Z., Zeng, Q., Liu, H., Qiu, W., & Wang, J. J. (2025) · Food Chemistry · doi:10.1016/j.foodchem.2025.143982 · Cited by 14
In Vivo Activity Profiling of Biosynthetic Darobactin D22 against Critical Gram-Negative Pathogens
Kany, A. M., Fries, F., Seyfert, C. E., Porten, C., Deckarm, S., Ortiz, M. C., Dubarry, N., Vaddi, S., Große, M., Bernecker, S., et al. (2024) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.4c00687 · Cited by 13
Cutting-edge tools for unveiling the dynamics of plasmid–host interactions
Yang, Q., Gao, J. T., Zhou, S. G., & Walsh, T. R. (2025) · Trends in Microbiology · doi:10.1016/j.tim.2024.12.013 · Cited by 14
Aerni, P. (2025) · Frontiers in Environmental Economics · doi:10.3389/frevc.2025.1498138 · Cited by 12
Li, Q., Zeng, C., Chen, Y., Ahmad, N., Zhang, S., & Zhou, C. (2025) · Chinese Journal of Chemistry · doi:10.1002/cjoc.70072 · Cited by 12
Lin, Y., Ye, Y., Zhang, Z., Zi, X., Zhang, J., & Zheng, C. (2025) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2025.137740 · Cited by 11
Cai, J., Yip, T. C., Wong, G. L.-H., Zhang, Y., Chan, P. P.-J., Liu, X., Zhang, T., Fong, A. T.-L., Chi, Z., Lai, K. M., et al. (2026) · Journal of Hepatology · doi:10.1016/j.jhep.2026.02.007 · Cited by 11
Synthetic Approaches, Properties, and Applications of Acylals in Preparative and Medicinal Chemistry
Keydel, T., & Link, A. (2024) · Molecules · doi:10.3390/molecules29184451 · Cited by 12
Antibiotic shortages: An overview by the alliance for the prudent use of antibiotics (APUA)
Allaw, F., Lan, H. V. T., Nagao, M., Ndegwa, L., Hara, G. L., Kanj, S. S., & Tattevin, P. (2025) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2025.107456 · Cited by 10
Mendelson, M., Afari-Asiedu, S., Schellack, N., Wertheim, H. F. L., Mpundu, M. M., & Gautham, M. (2025) · The Lancet Global Health · doi:10.1016/s2214-109x(25)00394-8 · Cited by 8
Self-citationVeronese, N., Barratt, J., Coemans, E., Dayananda, P., Riccio, M. D., Fülöp, T., Gabutti, G., Gravenstein, S., Hiligsmann, M., Hummers, E., et al. (2025) · Aging Clinical and Experimental Research · doi:10.1007/s40520-025-03271-6 · Cited by 8
Antimicrobial resistance survivors: calling the world to action
Shamas, N., Kariuki, J., Balasa, E., Kinamon, T., Liauw, F., Charles, S., Jaka, B., Purdie, R., Chavan, B., Lawal, M. O., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01030-4 · Cited by 8
Carbapenemases: epidemiology, detection and management in a changing global landscape
Maćešić, N., Harris, P. N. A., Mo, Y., & Gomez‐Simmonds, A. (2026) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlag099 · Cited by 7
Silva-Lagos, L., Ijaz, A., Buwalda, P. L., Kassai, S., Klostermann, C. E., Leemhuis, H., Veldhuizen, E. J. A., Schols, H. A., López‐Velázquez, G., & de Vos, P. (2024) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2024.122980 · Cited by 7
Maluleke, T. M., Maluleke, M. T., Golić-Jelić, A., Campbell, S., Marković‐Peković, V., Schellack, N., Chigome, A., Cook, A., Godman, B., & Meyer, J. C. (2025) · Frontiers in Tropical Diseases · doi:10.3389/fitd.2025.1637362 · Cited by 7
Historicising the “Empty Pipeline”: How Antibiotic Innovation Became a Market Failure (1980–2024)
Wells, N., Portillo, M. Y. A., Paterson, E. L., Vagneron, F., & Kirchhelle, C. (2025) · Public humanities. · doi:10.1017/pub.2025.10067 · Cited by 6
PathCrisp: an innovative molecular diagnostic tool for early detection of NDM-resistant infections
Patil, S., Siji, A., Mallur, D. J., Kruthika, B. S., Gheewalla, N., Karve, S. M., Kavathekar, M. S., Tarai, B., Naik, M., Hegde, V., et al. (2025) · Scientific Reports · doi:10.1038/s41598-024-84832-z · Cited by 5
Huang, S., Qian, Y., Wei, J., Chen, S., Shen, C., He, J., & Zhou, C. (2025) · ACS Macro Letters · doi:10.1021/acsmacrolett.5c00543 · Cited by 5
Anton, C.-I., Sima, C. S., Ștefan, I., & Jinga, V. (2026) · Microorganisms · doi:10.3390/microorganisms14010157 · Cited by 6
Mahrous, N. N., Fallatah, M., Fitaihi, R. A., Aldahshan, H., Alhhazmi, A., Al‐Khaldi, S., Fallatah, H., Althobaiti, A. A., Alkhoshaiban, A. S., Alguraini, J., et al. (2026) · Diagnostics · doi:10.3390/diagnostics16081239 · Cited by 6
Walker, M. K., Chishti, E. A., Yek, C., Sarzynski, S. H., Angelo, S., Cohn, J., Livinski, A. A., & Kadri, S. S. (2025) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2025.02.029 · Cited by 5
Self-citationHayashi, H., Saijo, E., Hirata, K., Murakami, S., Okuda, H., Kodama, E. N., Hasegawa, K., & Murayama, K. (2024) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2024.110160 · Cited by 5
Jørgensen, P. S., Nguyen-Thanh, L., Pehlivanoğlu, E., Klein, F., Wernli, D., Jasovský, D., Aktipis, A., Dunn, R. R., Grohn, Y. T., Lhermie, G., et al. (2025) · PLOS Global Public Health · doi:10.1371/journal.pgph.0004127 · Cited by 6
Group IB Metal‐Based Nanomaterials for Antibacterial Applications
Zhao, X., Wang, H., Sun, Y., Zhang, J., & Liu, H. (2025) · Small Science · doi:10.1002/smsc.202400412 · Cited by 5
Corral-Rodríguez, N. F., Moreno-Contreras, V. I., Sierra‐Campos, E., Valdez-Solana, M. A., Cisneros-Martínez, J. A., Téllez‐Valencia, A., & Avitia-Domínguez, C. I. (2025) · Biomolecules · doi:10.3390/biom15081137 · Cited by 4
Alsalman, J., Alawainati, M., Haji, S. M., & Shamas, N. (2025) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2025.102971 · Cited by 4
Fleck-Vidal, C., Doubell, A., Gerke, C., Lamichhane, U., Ogilvie, L. A., Sudbrak, R., Kim, J. H., Wartel, T. A., & Plant, L. (2025) · Vaccine · doi:10.1016/j.vaccine.2025.126771 · Cited by 4
Bacterial cell wall synthesis and recycling: new antimicrobial targets and vaccine development
Min, J., Kim, B., Park, Y., Son, Y., & Park, W. (2025) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2025.2510250 · Cited by 4
Chen, C., Li, S., Liu, J., Essack, S. Y., Luo, Y., Jong, M., Dai, X.-Y., Xu, Y., Korsten, L., Graham, D. W., et al. (2025) · Science China Life Sciences · doi:10.1007/s11427-025-2955-6 · Cited by 5
Bennett, A. N., Maziarz, J. F., Laipply, B., Cole, A. L., Woolard, K., Sorge, A., Zeiler, M. J., Melander, R. J., Melander, C., & Gunn, J. S. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1631575 · Cited by 4
Trends of serotypes and resistance among Streptococcus pneumoniae in the UK and Ireland (1999–2019)
Horner, C., Reynolds, R., Mushtaq, S., Chaudhry, A., Adkin, R., Allen, M., Longshaw, C. M., Parcell, B. J., & Livermore, D. M. (2025) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaf253 · Cited by 4
Kirchhelle, C., Portillo, M. A., Davis, M. D., Doron, A., Dreser, A., Fortané, N., Haddad, C., Hinchliffe, S., Kariuki, S., Lewycka, S. O., et al. (2026) · The Lancet Microbe · doi:10.1016/j.lanmic.2025.101315 · Cited by 5
Recent Advances in Crystalline Porous Materials for Antibacterial Applications
Wu, P., Wei, L., Yao, R., Liu, B., Yang, S., Qiao, L., Wang, X., Gong, W., Liu, Y. J., Cui, Y. Y., et al. (2025) · Chemistry - An Asian Journal · doi:10.1002/asia.202401961 · Cited by 4
Wang, J., Wang, Y., Su, Y., Gong, H., Han, X., Ma, S., Sun, D., Liu, Y., Chen, W., Zhang, M., et al. (2025) · Inorganic Chemistry Communications · doi:10.1016/j.inoche.2025.115385 · Cited by 3
Feng, W., Huang, S., Yi, A., Wang, X., Wu, Y., Li, X., Yang, N., Fan, L., Guo, G., & Zheng, J. (2025) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2025.110952 · Cited by 3
Chiral peptidoglycan mimics target bacterial wall biosynthesis for pathogen intervention
Deng, K., Zou, D., Zeng, Z., Guo, B., Gong, W., Xu, Y., Li, Y., & Xu, X. (2026) · Nature Communications · doi:10.1038/s41467-026-69967-z · Cited by 5
Raycheva, R., Ленгерова, Г., Petrov, M. M., & Kantardjiev, T. (2026) · Microorganisms · doi:10.3390/microorganisms14050994 · Cited by 3
Maluleke, T. M., Maluleke, M. T., Golić-Jelić, A., Campbell, S., Marković‐Peković, V., Schellack, N., Ramdas, N., Godman, B., & Meyer, J. C. (2025) · Frontiers in Tropical Diseases · doi:10.3389/fitd.2025.1637843 · Cited by 4
Regional disparities of infections in cirrhosis: a call for action
Verma, N., & Piano, S. S. (2024) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(24)00266-8 · Cited by 3
Lubell, Y., Do, N. T. T., Lewycka, S. O., Onwunduba, A., van Doorn, H. R., & Wertheim, H. F. L. (2024) · The Lancet Global Health · doi:10.1016/s2214-109x(24)00382-6 · Cited by 3
Self-citationChandramouli, M. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4876037 · Cited by 3
Çolak, A., Dik, G., Ulu, A., Kahraman, H., & Ateş, B. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.107034 · Cited by 2
Zhong, R., Xu, L., Wu, J., He, M., Wu, S., Luo, Z., Han, N., Yao, Y., Zhou, J., Ruan, Z., et al. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.118290 · Cited by 2
Impalli, I., Kalanxhi, E., Street, H. R., Kumar, C. K., & Laxminarayan, R. (2026) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2025.0002 · Cited by 2
Self-citationXu, B., Liu, L., Fu, H., Liu, M., & Li, X. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1783836 · Cited by 2
Meeting the 2024 UN General Assembly declaration targets on antimicrobial resistance
Laxminarayan, R., Limmathurotsakul, D., de Abreu, A. L., Alimi, Y. H., Karkey, A., Kanj, S. S., Mendelson, M., & Cars, O. (2026) · The Lancet · doi:10.1016/s0140-6736(26)00979-7 · Cited by 2
Self-citationAntibacterial drug discovery: challenges and preclinical promises from synthetic small molecules
Fernandes, G., Kim, S., dos Santos, J. L., Wang, Y., Soudy, C., Redmond, J. M., Castagnolo, D., & Todd, M. H. (2026) · Chemical Society Reviews · doi:10.1039/d5cs00617a · Cited by 4
Abid, M. A., Al-Jumaili, M. A.-J., & Abed, A. A. (2025) · Results in Chemistry · doi:10.1016/j.rechem.2025.102042 · Cited by 2
Beyond high cost: Pharmaceutic low-resource setting barriers to antibacterial access
Adeoye, M., Agboeze, C. T., Adegoke, J. A., & Okeke, I. N. (2025) · PLOS Global Public Health · doi:10.1371/journal.pgph.0004280 · Cited by 2
Li, X., Qiu, S., Liu, C., Zhao, M., Yang, X., Xia, H., Wang, R., Chen, S., Chen, J., Zheng, J., et al. (2025) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2025.107889 · Cited by 2
Huang, Y., Nie, Q., Chen, Z., Gong, W., Cao, W., Wang, X., Liu, Y., & Meng, Z. (2025) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2025.102159 · Cited by 1
Liao, Z., Su, X., Luo, T., Zhao, X., Guo, Y., Xu, X., Wang, F., Luo, G., & Zhan, R. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102594 · Cited by 1
Avellar, M. L. D., Hafeez, H., Hammond, R., & Samuel, I. D. W. (2026) · Scientific Reports · doi:10.1038/s41598-025-34122-z · Cited by 1
Raycheva, R., Lengerova, G., Petrov, M. M., & Kantardjiev, T. (2026) · Microorganisms · doi:10.3390/microorganisms14030675 · Cited by 1
Point of care antimicrobial susceptibility testing
Couwenberg, J., van Belkum, A., van de Kerkhof, D., Scharnhorst, V., Wertheim, H. F. L., van der Linden, A. J., & van Asten, S. A. V. (2026) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-026-05453-0 · Cited by 1
Self-citationTzialla, C., Salomè, S., Mondı̀, V., Salvo, V., & Berardi, A. (2026) · Antibiotics · doi:10.3390/antibiotics15030306 · Cited by 1
Cingolani, A., Serraino, R., Cagnoni, F., Chiuchiarelli, M., Monolo, G., Frondizi, F., Bahatungire, R. R., Destro, M., & Torti, C. (2026) · BMC Infectious Diseases · doi:10.1186/s12879-026-13269-8 · Cited by 1
The global surge of drug-resistant infections and what it reveals about our failing defenses
Gulumbe, B. H., Abdulrahim, A., Alum, E. U., Faggo, A. A., Abubakar, T. M., & Adepoju, V. A. (2026) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2026.2684571 · Cited by 1
Mangana, M., Lambrinidis, G., Kostakis, I. K., Kalpaktsi, I., Sagnou, M., Nicolaou, C., Mikros, E., Chatzipanagiotou, S., & Ioannidis, A. (2024) · Antibiotics · doi:10.3390/antibiotics14010011 · Cited by 1
PathCrisp: An Innovative Molecular Diagnostic Tool for Early Detection of NDM-Resistant InfectionsPreprint
Arora, R., Patil, S., Siji, A., Mallur, D. J., Gheewalla, N., Karve, S. M., Kavathekar, M. S., Tarai, B., Naik, M., S., K. B., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4713933/v1 · Cited by 1
Hillock, N. T., Cheng, A., & Bowskill, A. (2024) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlae216
Feng, W., Huang, S., Yi, A., Wang, X., Wu, Y., Li, X., Yang, N., Fan, L., Guo, G., & Jiping, Z. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5398455
Zhi, Y., Wang, S., Zhang, H., Xue, G., & Zhang, Z. (2025) · Polymers · doi:10.3390/polym17192636
Zhang, M., Dong, J., Zhang, L., Lv, Y., Guo, Y., & Wang, Z. (2025) · Applied Biochemistry and Microbiology · doi:10.1134/s0003683825601428
Armas, I. I. G., Fierro, D. N., & Patiño, F. L. P. (2025) · Arandu-UTIC. · doi:10.69639/arandu.v12i4.1666
A Review of Comparative Strategies Against Pneumonia: Vaccine and Antibiotic Resistance Mitigation
Ahmed, M., Ahmad, M., Hussain, H., Rizwan, Nadeem, Z., Mustehsan, M., Sami, A., Kanwal, H., Akbar, S. S., Ali, M., et al. (2025) · The Open Microbiology Journal · doi:10.2174/0118742858424997251105071208 · Cited by 1
Deng, J.-H., Ji, J., Khan, A., Wang, Z., Xiang, W. D., Qiao, H., Salama, E., Gu, J., Mao, C., Liu, P., et al. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-025-10873-z
Expanding Access: Logistics at the Heart of Cardiac Surgery in Africa
Erez, E., Dorton, C. W., & DiMaio, J. M. (2026) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2025.11.021
Metadata
- Authors
- Laxminarayan, R., Impalli, I., Rangarajan, R., Cohn, J., Ramjeet, K., Trainor, B. W., Strathdee, S., Sumpradit, N., Berman, D., Wertheim, H., Outterson, K., Srikantiah, P., & Theuretzbacher, U.
- Affiliations
- Princeton University (US)
- Central Drug Research Institute (IN)
- Global Antibiotic Research & Development Partnership (CH)
- FIND (CH)
- Boston University (US)
- University of California San Diego (US)
- Ministry of Public Health (TH)
- Radboud University Medical Center (NL)
- Gates Foundation (US)
- Corresponding author
- Laxminarayan, Ramanan
- ORCID
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2024-06
- Volume
- 403
- Issue
- 10443
- Pages
- 2534-2550
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W4398244676
- Cited by
- 111
- References
- 98
- Citations by year
- 2026: 32 · 2025: 54 · 2024: 25
- FWCI
- 4.65
- Type
- journal article
- Language
- en
- Open access
- green
- repository.ubn.ru.nl
- Licence
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Radboud Repository (Radboud University) (submittedVersion, other-oa)
- bepress Legal Repository (submittedVersion)
- Funders
- Bill and Melinda Gates Foundation
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Keywords
- antimicrobial resistance, antibiotic development, vaccine development, diagnostics, public-private partnerships, drug development incentives, access to medicines, low- and middle-income countries, clinical trial networks, platform technology, infection control, antibiotic stewardship, drug-resistant pathogens, out-of-pocket costs
- MeSH terms
- Drug Development, COVID-19, SARS-CoV-2, Anti-Bacterial Agents, Bacterial Infections, Health Services Accessibility, Humans, Drug Resistance, Bacterial, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
